Sign Out
Pregnancy: Pregnancy Category C.
Third trimester: Neonates exposed to antipsychotics (including quetiapine) during the third trimester of pregnancy are at risk of adverse reactions including extrapyramidal symptoms and/or withdrawal symptoms that may vary in severity and duration following delivery. There have been reported of agitation, hypertonia, tremor, somnolence, respiratory distress, or feeding disorder. Consequently, newborns should be monitored carefully.
Breast-feeding: Based on very limited data from published reports on quetiapine excretion into human breast milk, quetiapine therapy taking into account the benefit of breast feeding for the child and the benefit of therapy for the woman.
Continue with Google